US Stock MarketDetailed Quotes
IMNN Imunon
- 0.812
- +0.119+17.17%
Close Nov 22 16:00 ET
- 0.800
- -0.012-1.47%
Post 19:20 ET
11.77MMarket Cap-425P/E (TTM)
0.830High0.690Low296.79KVolume0.690Open0.693Pre Close232.16KTurnover2.15%Turnover RatioLossP/E (Static)14.50MShares3.65052wk High1.44P/B11.20MFloat Cap0.48052wk Low--Dividend TTM13.79MShs Float145293.750Historical High--Div YieldTTM20.20%Amplitude0.480Historical Low0.782Avg Price1Lot Size
About Imunon Company
Imunon, Inc. is a clinical stage oncology drug company. It focuses on cancer treatments, including directed chemotherapies, DNA-mediated immunotherapy and RNA-based therapies. The firm is also engaged in the research and development of pharmaceutical products for cancer treatments. Its portfolio includes deoxyribonucleic acid-mediated immunotherapy and ribonucleic acid-based therapies. It operates through the Celsion and ThermoDox brands. The company was founded by Yim-Pan Cheung in 1982 and is headquartered in Lawrenceville, NJ.
Company Profile
SymbolIMNN
Company NameImunon
Listing DateFeb 8, 2008
Founded1982
CEODr. Stacy R. Lindborg, PhD
MarketNASDAQ
Employees33
Fiscal Year Ends12-31
Address997 Lenox Drive,Suite 100
CityLawrenceville
ProvinceNew Jersey
CountryUnited States of America
Zip Code08648
Phone1-609-896-9100
Websitehttp://imunon.com
Company Executives
- Name
- Position
- Salary
- Dr. Stacy R. Lindborg, PhD
- Director, President and Chief Executive Officer
- 44.10K
- Dr. Khursheed Anwer, M.B.A.,PhD
- Executive Vice President and Chief Scientific Officer
- 680.16K
- Dr. Sebastien Hazard, M.D.
- Executive Vice President and Chief Medical Officer
- --
- David Gaiero
- Chief Financial Officer and Chief Accounting Officer
- --
- Kimberly A. Graper
- Vice President of Finance and Controller
- --
- Michael H. Tardugno
- Executive Chairman of the Board
- --
- Christine A. Pellizzari
- Independent Director
- 47.70K
- James E. Dentzer
- Independent Director
- 61.20K
- Frederick J. Fritz
- Independent Director
- 106.20K
- Dr. Donald Braun, PhD
- Independent Director
- 72.90K
- Susan Eylward
- General Counsel and Corporate Secretary
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
